A Case Series of Molecular Imaging of Glucagonoma After Initial Therapy-68Ga-DOTATATE PET/CT Reveals Similar Results as in Neuroendocrine Tumors of Other Origin in Follow-up and Re-evaluation.

Rottenburger, Christof; Papantoniou, Dimitrios; Mandair, Dalvinder; Caplin, Martyn; Navalkissoor, Shaunak

Rottenburger, Christof; Papantoniou, Dimitrios; Mandair, Dalvinder; Caplin, Martyn; Navalkissoor, Shaunak.

Clin Nucl Med ; 43(4): 252-255, 2018 Apr.

Article in En | MEDLINE | ID: mdl-29432346

Subject(s)

Glucagonoma/diagnostic imaging; Glucagonoma/therapy; Neuroendocrine Tumors/diagnostic imaging; Neuroendocrine Tumors/therapy; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Aged; Female; Follow-Up Studies; Glucagonoma/metabolism; Glucagonoma/pathology; Humans; Male; Middle Aged; Neuroendocrine Tumors/metabolism; Neuroendocrine Tumors/pathology; Receptors, Somatostatin/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Neuroendocrine Tumors / Positron Emission Tomography Computed Tomography / Glucagonoma Type of study: Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Nucl Med Year: 2018 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google